Skip to main content
Clinical Trials/NCT02896699
NCT02896699
Completed
Not Applicable

Advanced HIV Prevention (PrEP Chicago)

University of Chicago1 site in 1 country424 target enrollmentMarch 2016
ConditionsHIV

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV
Sponsor
University of Chicago
Enrollment
424
Locations
1
Primary Endpoint
Network member call into the PrEPline
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study will evaluate the feasibility of a network intervention to train individuals to disseminate PrEP information and motivate initial PrEP interest and knowledge of PrEP in their social networks.

Detailed Description

The specific aims of this study are: 1. To recruit 450 participants in Chicago, Illinois, and to train them as peer change agents (randomized to cross-over groups) to disseminate PrEP information and motivate PrEP interest and knowledge of PrEP in their local networks. 2. To evaluate feasibility of the program over 2 years of participant follow-up through: 1) peer change agent exit survey; 2) peer change agent booster sessions; 3) peer change agent communication with University of Chicago PrEP program social media; 4) referrals into the project and; 5) calls into the PrEP warmline.

Registry
clinicaltrials.gov
Start Date
March 2016
End Date
August 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Lives on the South Side of Chicago, Illinois
  • Born male
  • Has had sex with men in the previous year
  • Is an active Facebook user
  • Does not have plans to leave Chicago

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Network member call into the PrEPline

Time Frame: 2 years

Secondary Outcomes

  • PrEP Attitudes questionnaire(2 years)
  • Peer change agent boosters sessions completed(2 years)
  • Number of Facebook posts with respect to PrEP and sexual health(2 years)
  • Number of referrals enrolled into the study(2 years)

Study Sites (1)

Loading locations...

Similar Trials